Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 280-631-8 | CAS number: 83732-80-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- one-generation reproductive toxicity
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- Data is from publication
Data source
Reference
- Reference Type:
- publication
- Title:
- Effects of FD & C red no. 40 on rat intrauterine development
- Author:
- T. F. X. COLLINS and T. N. BLACK
- Year:
- 1 980
- Bibliographic source:
- Food and cosmatics toxicology, Vol. 18. pp 561 to 568, 1980
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Principles of method if other than guideline:
- Embryotoxicity and teratogenicity study of FD & C RED NO. 40 in rats
- GLP compliance:
- not specified
- Limit test:
- no
Test material
- Reference substance name:
- Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate
- EC Number:
- 247-368-0
- EC Name:
- Disodium 6-hydroxy-5-[(2-methoxy-4-sulphonato-m-tolyl)azo]naphthalene-2-sulphonate
- Cas Number:
- 25956-17-6
- Molecular formula:
- C18H16N2O8S2.2Na
- IUPAC Name:
- disodium 6-hydroxy-5-[(2-methoxy-3-methyl-4-sulfonatophenyl)diazenyl]naphthalene-2-sulfonate
- Reference substance name:
- FD & C RED NO. 40
- IUPAC Name:
- FD & C RED NO. 40
- Details on test material:
- - Name of test material (as cited in study report): FD & C RED NO. 40 (disodium salt of 6-hydroxy-5-[(2-methoxy-5-methyl-4-sulph ophenyl)azo]-2-naphthalene sulphonic acid.)
- Molecular formula (if other than submission substance): C18H16N2O8S2.2Na
- Molecular weight (if other than submission substance): 496.4266 g/mole
- Substance type: Oragnic
- Physical state: No data available
- Impurities (identity and concentrations): 5.30% NaC1, 4.50% volatile matter,0.3 % Na2SO4 and 0.26% Schaeffer's salt (an intermediate).
Constituent 1
Constituent 2
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): FD & C RED NO. 40 (disodium salt of 6-hydroxy-5-[(2-methoxy-5-methyl-4-sulph ophenyl)azo]-2-naphthalene sulphonic acid.)
- Molecular formula (if other than submission substance): C18H16N2O8S2.2Na
- Molecular weight (if other than submission substance): 496.4266 g/mole
- Substance type: Oragnic
- Physical state: No data available
- Impurities (identity and concentrations): 5.30% NaC1, 4.50% volatile matter,0.3 % Na2SO4 and 0.26% Schaeffer's salt (an intermediate).
Test animals
- Species:
- rat
- Strain:
- Osborne-Mendel
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: FDA breeding colony
- Age at study initiation: (P) x wks; (F1) x wks: No data available
- Weight at study initiation: (P) Males: x-x g; Females: x-x g; (F1) Males: x-x g; Females: x-x g: P- female – 124.1 to 134.8 g
- Fasting period before study: No data available
- Housing: Animals were housed in stainless-steel hanging cages.
- Diet (e.g. ad libitum): Purina Laboratory Chow (Ralston-Purina Co., Inc., St. Louis, MO), ad libitum
- Water (e.g. ad libitum): Distilled water, ad libitum
- Acclimation period: No data available
ENVIRONMENTAL CONDITIONS
- Temperature (°C): No data available
- Humidity (%):No data available
- Air changes (per hr): No data available
- Photoperiod (hrs dark / hrs light): 12 hr darkness and 12 hr light.
Administration / exposure
- Route of administration:
- oral: drinking water
- Type of inhalation exposure (if applicable):
- not specified
- Vehicle:
- other: Distilled water
- Details on exposure:
- No data available
- Details on mating procedure:
- - M/F ratio per cage: 1:2 ratio
- Length of cohabitation: 4.30p.m. to following morning
- Proof of pregnancy: [vaginal plug / sperm in vaginal smear] referred to as [day 0 / day 1] of pregnancy Presence of sperm in the vaginal lavage were referred to as day 0 of pregnancy
- After ... days of unsuccessful pairing replacement of first male by another male with proven fertility: No data available
- Further matings after two unsuccessful attempts: [no / yes (explain)]: No data available
- After successful mating each pregnant female was caged (how): No data available
- Any other deviations from standard protocol: Within each group a male impregnated a maximum of two females. - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- The dye solutions were found to be stable for the duration of the experiment
- Duration of treatment / exposure:
- 19 days
- Frequency of treatment:
- Daily
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day
- Dose / conc.:
- 260.2 mg/kg bw/day
- No. of animals per sex per dose:
- Totol: 55
0 mg/kg bw/day: 30
260.2 mg/kg bw/day: 25 - Control animals:
- yes, concurrent vehicle
Examinations
- Parental animals: Observations and examinations:
- Clinical signs , Body weight, water consumption were examihned.
- Oestrous cyclicity (parental animals):
- Any irregularity in Estrous cyclicity were examined.
Presence and location of resorption sites and implantation sites Corpora lutea were examined. - Sperm parameters (parental animals):
- No data available
- Litter observations:
- Live and dead foetuses, weight and sexed were examined.
- Postmortem examinations (parental animals):
- No data available
- Postmortem examinations (offspring):
- Gross external malformationsunder magnification, and the crown-rump length and soft tissues variations was measured.
- Statistics:
- Statistical analysis were performed by using a least significant difference (LSD) test for numbers of corpora lutea per dam, implantations per dam, numbers of viable implants per dam, foetal body weights and crown-rump lengths. Freeman-Tukey arc-sine transformation for binomial proportions (Mosteller & Youtz, 1961) followed by an analysis of variance and an LSD test used for The number of resorptions per litter and the average number of foetuses with one or more variations per litter. Preimplantation loss data were transformed using the Freeman-Tukey arc-sine transformation followed by an analysis of variance and an LSD test. The numbers of litters with one or more resorptions, one or more skeletal or soft tissue variations and specific external, soft-tissue and skeletal variations were analysed by Fisher's exact one-tail test (Siegel, 1956). An analysis of variance was used to test maternal weight gain. An Armitage lest for linearity of proportions (Armitage, 1973) was also used to detect trends. Differences in water consumption were analysed by a paired t-test.
- Reproductive indices:
- No data available
- Offspring viability indices:
- No data available
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Description (incidence and severity):
- No external signs of toxicity and animals appeared healthy and behaved normally in treated groups as compared to control.
- Dermal irritation (if dermal study):
- not specified
- Mortality:
- not specified
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No effect on maternal weight gain was observed in treated groups as compared to control.
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- effects observed, treatment-related
- Description (incidence and severity):
- Significant decrease in water consumption was observed in treated rats as compare to control.
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Behaviour (functional findings):
- not specified
- Immunological findings:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Histopathological findings: non-neoplastic:
- not specified
- Histopathological findings: neoplastic:
- not specified
- Other effects:
- not specified
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- no effects observed
- Description (incidence and severity):
- No significant changes in or treatment-related effects on the numbers of corpora lutea, implantations, early and late deaths and viable foetuses per litter or on the percentage of preimplantation loss were observed in treated group as compared to control.
- Reproductive function: sperm measures:
- not specified
- Reproductive performance:
- no effects observed
- Description (incidence and severity):
- No significant effect on percentage of early resorptions and percentage of females with more than one and with more than two resorptions were observed in treated rats as compared to control.
Effect levels (P0)
- Dose descriptor:
- NOAEL
- Effect level:
- 260.2 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- female
- Basis for effect level:
- clinical signs
- body weight and weight gain
- reproductive function (oestrous cycle)
- reproductive performance
- Remarks on result:
- other: No effect observed
Target system / organ toxicity (P0)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- not specified
- Dermal irritation (if dermal study):
- not specified
- Mortality / viability:
- no mortality observed
- Description (incidence and severity):
- No effect on live or dead fetuses was observed in treated dose groups as compared to control.
- Body weight and weight changes:
- no effects observed
- Description (incidence and severity):
- No effect on mean fetal body weight was observed in treated groups as compared to control.
- Food consumption and compound intake (if feeding study):
- not specified
- Food efficiency:
- not specified
- Water consumption and compound intake (if drinking water study):
- not specified
- Ophthalmological findings:
- not specified
- Haematological findings:
- not specified
- Clinical biochemistry findings:
- not specified
- Urinalysis findings:
- not specified
- Sexual maturation:
- not specified
- Organ weight findings including organ / body weight ratios:
- not specified
- Gross pathological findings:
- no effects observed
- Description (incidence and severity):
- When treated with 260.2 mg/kg bw/day, No treatment related external variations were observed in litters of treated dams as compared to control.
Number of runts: Increase in number of runts was observed in litters of treated rats as compared to control. - Histopathological findings:
- no effects observed
- Description (incidence and severity):
- Soft-tissue variations: slight increase in number of affected litters was observed in 260.2 mg/kg bw/day treated rats as compared to control.
Skeletal variations:
Slight increase in the number of bipartite sternebrae and reduced ossification of the parietal bone were observed in litters of treated dams as compared to control.
The observed increases did not appear to be dose-related. - Other effects:
- no effects observed
- Description (incidence and severity):
- Crown-rump length: No effect on Crown-rump length were observed in litters of treated dams as compared to control.
Sex distribution: No effect on Sex distribution were observed in litters of treated dams as compared to control.
Developmental neurotoxicity (F1)
- Behaviour (functional findings):
- not specified
Developmental immunotoxicity (F1)
- Developmental immunotoxicity:
- not specified
Effect levels (F1)
- Dose descriptor:
- NOAEL
- Generation:
- F1
- Effect level:
- 260.2 mg/kg bw/day
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- mortality
- body weight and weight gain
- gross pathology
- histopathology: non-neoplastic
- Remarks on result:
- other: No effect on Live and dead foetuses, weight, sex, gross pathology and histopathiology
Target system / organ toxicity (F1)
- Critical effects observed:
- not specified
- System:
- other: not specified
- Organ:
- not specified
- Treatment related:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
- Treatment related:
- not specified
- Relation to other toxic effects:
- not specified
- Dose response relationship:
- not specified
- Relevant for humans:
- not specified
Any other information on results incl. tables
Maternal and reproductive data for rats given FD & C red no 40 during gestation
|
|
|
Autopsy finding (mean/dam) |
|
|
Females with Resorption (%) |
|||||
|
|
|
|
|
Resorption |
|
|
|
One or more |
Two or more |
|
Mode of addministration and dose level |
no. Of pregnant females examined |
mean maternal body weigh tgain (g)* |
Corpora lutea* |
implantations* |
Early |
Late |
Viable foetuses* |
Resorption (%) |
Preimplantation |
|
|
Intubation (%) |
|
|
|
|
|
|
|
|
|
|
|
0 |
30 |
147.0 ± 3.6 |
13.4 ± 0.4 |
12.0 ± 0.5 |
0.5 |
0 |
11.5±0.5 |
4.4 |
10.4 |
43.3 |
10.0 |
0.2 |
25 |
147.5 ± 4.1 |
13.6 ± 0.3 |
12.7 ± 0.3 |
0.6 |
0 |
12.0±0.3 |
5.0 |
7.0 |
48.0 |
16.0 |
*Values are means ± SEM.
Incidence of specifice external and soft tissue variations of foetuses of rats given FD & C red no 40 during gestation
|
|
Incidence* in foetuses and litters of rats administered FD & C red no 40 |
||
|
|
In the drinking water |
||
Variation |
Dose level† |
0 |
0.2 |
|
|
|
External examinations |
||
No. Examined |
|
345 (30) |
301 (25) |
|
Runt |
|
1 (1) |
4 (4) |
|
Oedema |
|
2 (1) |
|
|
Cranial pimple |
|
1 (1) |
|
|
Exencephaly |
|
1 (1) |
|
|
|
|
Soft tissue examination |
||
No. Examined |
|
180 (30) |
161 (25) |
|
Hydrourter: moderate |
|
7 (5) |
7 (5) |
|
sever |
|
1 (1) |
1 (1) |
|
Hydronephrosis: moderate |
|
8 (4) |
6 ()5 |
|
sever |
|
1 (1) |
1 (1) |
|
Ectopic kidney |
|
2 (2) |
1 (1) |
|
Pitted kidney |
|
1 (1) |
1 (1) |
|
Deformed kidney |
|
1 (1) |
|
|
Haemorrhage |
|
13 (8) |
8 (7) |
|
Hydrocephalus |
|
2 (1) |
1 (1) |
|
Microphthalmia |
|
1 (1) |
|
|
oesophageal pouch |
|
1 (1) |
|
|
* No. Of foetuses affected and in parentheses, no of litters.
†The dose level is expressed as mg/kg/day as a percentage in the drinking water
Incidence of soft – tissue variations in foetusees of rats given FD & C red no 40 during gestation
|
Soft tissue variations |
Foetuses with one or more Soft tissue variations |
Litters with one or more foetuses with variations |
||||
Drinking water (%) |
Total |
Mean/litter |
No. |
Mean/litter |
% of total foetuses |
No. |
% of total litters |
0 |
37 |
1.2 |
28 |
0.9 |
15.6 |
13 |
43.3 |
0.2 |
25 |
1.0 |
17 |
0.7 |
10.6 |
14 |
56.0 |
Incidence of sternebral variations in foetusees of rats given FD & C red no 40 during gestation
|
Soft tissue variations |
Foetuses with one or more Soft tissue variations |
Litters with one or more foetuses with variations |
||||
Drinking water (%) |
Total |
Mean/litter |
No. |
Mean/litter |
% of total foetuses |
No. |
% of total litters |
0 |
57 |
1.9 |
49 |
1.6 |
30.2 |
22 |
73.3 |
0.2 |
58 |
2.3 |
52 |
2.1 |
37.1 |
20 |
80.0 |
Incidence of Skeletal variations in foetusees of rats given FD & C red no 40 during gestation
|
Soft tissue variations |
Foetuses with one or more Soft tissue variations |
Litters with one or more foetuses with variations |
||||
Drinking water (%) |
Total |
Mean/litter |
No. |
Mean/litter |
% of total foetuses |
No. |
% of total litters |
0 |
56 |
1.9 |
42 |
1.4 |
25.9 |
21 |
70.0 |
0.2 |
58 |
2.3 |
31 |
1.2 |
22.1 |
14 |
56.0 |
Applicant's summary and conclusion
- Conclusions:
- NOAEL was considered to be 260.2 mg/kg body weight /day for F0 and F1 generation when Osborne-Mendel female rats were treated wtih FD & C RED NO. 40.
- Executive summary:
In a Embryotoxicity and teratogenicity study, Osborne-Mendel female rats were treated with FD & C RED NO. 40 in the concentration of 260.2 mg/kg body weight /day in distilled water by oral drinking water. No external signs of toxicity and animals were appeared healthy and behaved normally in treated groups as compared to control. No effects on maternal weight gain and significant decrease in water consumption were observed in treated female rats as compared to control. No significant effects on numbers of corpora lutea, implantations, early and late deaths and viable foetuses per litter or on the percentage of preimplantation loss were observed in treated group as compared to control. Similarly, no significant effect on percentage of early resorptions and percentage of females with more than one and with more than two resorptions were observed in treated rats as compared to control. In addition, No effect on live or dead fetuses and mean fetal body weight and percentage of males and females per treatment group were observed as compared to control. Increase in number of runts was observed in litters, but no external variations were observed in litters of treated dams as compared to control. No effect on Crown-rump length and Sex distribution were observed in litters of treated dams as compared to control. Slight increase in number of affected litters, number of bipartite sternebrae and reduced ossification of the parietal bone were observed in litters of treated dams as compared to control. But, the observed increases did not appear to be dose-related. Therefore, NOAEL was considered to be 260.2mg/kg body weight /day for F0 and F1 generation when Osborne-Mendel female rats were treated with FD & C RED NO. 40. orally in Drinking water for 19 days.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.